BARTELS CYTOMEGALOVIRUS IGG EIA— 510(k) K922582

Substantially Equivalent

Baxter Diagnostics, Inc.

FDA 510(k) clearance K922582 for BARTELS CYTOMEGALOVIRUS IGG EIA, Substantially Equivalent on 1993-04-08. Applicant: Baxter Diagnostics, Inc..

Clearance details

Applicant: Baxter Diagnostics, Inc.
Product code: Code LFZ
Advisory panel: Microbiology
Date received: 1992-05-27
Decision date: 1993-04-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.